Biocept
BIOC
$0.43
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)
Categories
EPS for Biocept (BIOC)
EPS in 2023 (TTM): -$50.90
According to Biocept 's latest financial reports the company's current EPS (TTM) is -$50.90. In 2022 the company made an earnings per share (EPS) of -$56.82 a decrease over its 2021 EPS that were of -$5.10.
EPS history for Biocept from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$50.90 | -10.42% |
| 2022 | -$56.82 | 1014.12% |
| 2021 | -$5.10 | -90.56% |
| 2020 | -$54.00 | -87.47% |
| 2019 | -$431.10 | -85.46% |
| 2018 | -$2,964 | -58.7% |
| 2017 | -$7,176 | -62.38% |
| 2016 | -$19,074 | -21.83% |
| 2015 | -$24,401 | -74.78% |
| 2014 | -$96,744 | 74.98% |
| 2013 | -$55,289 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | -$0.40 | -99.21% | 🇺🇸 USA |
 Exact Sciences EXAS | -$1.59 | -96.88% | 🇺🇸 USA |
 Myriad Genetics MYGN | -$3.04 | -94.03% | 🇺🇸 USA |